Phil Greenberg (IMAGE) Fred Hutchinson Cancer Center Caption 'Our results highlight that driver mutations, which theoretically would be the most effective antigens to target because they represent the basis for a tumor behaving as a tumor, are not immunologically silent and can indeed be recognized,' said Fred Hutchinson Cancer Research Center immunologist Dr. Phil Greenberg, who led the study. Credit Fred Hutch News Service Usage Restrictions No restrictions, but please attribute appropriately. License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.